AbbVie Inc.
Status: Publicly traded
Direct answer
AbbVie Inc. is publicly traded on NYSE under the ticker ABBV.
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in...
Can you invest in AbbVie Inc.?
Yes. AbbVie Inc. trades publicly on NYSE as ABBV.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.